Expression of human CAR splicing variants in BAC-transgenic mice

Toxicological Sciences

Volumn 132, Issue 1, 2013, Pages 142-150

  Zhang, Yu Kun Jennifer ^a   Lu, Hong ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Bac; Car; In vivo; Splicing variant; Transgenic mice

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; GENOMIC DNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROCESSING; TISSUE DISTRIBUTION;

ANIMALS; BLOTTING, WESTERN; CHROMOSOMES, ARTIFICIAL, BACTERIAL; HUMANS; JEJUNUM; LIVER; MICE; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS; MUS MUSCULUS;

EID: 84876474301     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs321     Document Type: Article

References (28)

1. Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004). Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279, 22250-22257.
2. Auerbach, S. S., Stoner, M. A., Su, S., and Omiecinski, C. J. (2005). Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol. Pharmacol. 68, 1239-1253.
3. Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., and Moore, D. D. (1994). A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544-1552.
4. Choi, H. S., Chung, M., Tzameli, I., Simha, D., Lee, Y. K., Seol, W., and Moore, D. D. (1997). Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272, 23565-23571.
5. DeKeyser, J. G., Stagliano, M. C., Auerbach, S. S., Prabhu, K. S., Jones, A. D., and Omiecinski, C. J. (2009). Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2. Mol. Pharmacol. 75, 1005-1013.
6. Dring, A. M., Anderson, L. E., Qamar, S., and Stoner, M. A. (2010). Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. Chem. Biol. Interact. 188, 512-525.
7. Forman, B. M., Tzameli, I., Choi, H. S., Chen, J., Simha, D., Seol, W., Evans, R. M., and Moore, D. D. (1998). Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395, 612-615.
8. Haurogne, K., Bach, J. M., and Lieubeau, B. (2007). Easy and rapid method of zygosity determination in transgenic mice by SYBR Green real-time quantitative PCR with a simple data analysis. Transgenic Res. 16, 127-131.
9. Hernandez, J. P., Mota, L. C., and Baldwin, W. S. (2009). Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr. Pharmacogenomics Person. Med. 7, 81-105.
10. Honkakoski, P., Zelko, I., Sueyoshi, T., and Negishi, M. (1998). The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18, 5652-5658.
11. Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., and Moore, D. D. (2003). Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 100, 4156-4161.
12. Huang, W., Zhang, J., Wei, P., Schrader, W. T., and Moore, D. D. (2004). Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol. Endocrinol. 18, 2402-2408.
13. Jinno, H., Tanaka-Kagawa, T., Hanioka, N., Ishida, S., Saeki, M., Soyama, A., Itoda, M., Nishimura, T., Saito, Y., Ozawa, S., et al. (2004). Identification of novel alternative splice variants of human constitutive androstane receptor and characterization of their expression in the liver. Mol. Pharmacol. 65, 496-502.
14. Lamba, J. K., Lamba, V., Yasuda, K., Lin, Y. S., Assem, M., Thompson, E., Strom, S., and Schuetz, E. (2004). Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 311, 811-821.
15. Lamba, V., Lamba, J., Yasuda, K., Strom, S., Davila, J., Hancock, M. L., Fackenthal, J. D., Rogan, P. K., Ring, B., Wrighton, S. A., et al. (2003). Hepatic CYP2B6 expression: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther. 307, 906-922.
16. Ledda-Columbano, G. M., Pibiri, M., Concas, D., Molotzu, F., Simbula, G., Cossu, C., and Columbano, A. (2003). Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP. Carcinogenesis 24, 1059-1065.
17. Lee, J. S., Ward, W. O., Knapp, G., Ren, H., Vallanat, B., Abbott, B., Ho, K., Karp, S. J., and Corton, J. C. (2012). Transcriptional ontogeny of the developing liver. BMC Genomics 13, 33.
18. Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., and Misteli, T. (2011). Epigenetics in alternative pre-mRNA splicing. Cell 144, 16-26.
19. Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M., and Misteli, T. (2010). Regulation of alternative splicing by histone modifications. Science 327, 996-1000.
20. Nims, R. W., Beebe, L. E., Utermahlen, W. E. Jr., Thomas, P. E., and Lubet, R. A. (1999). Induction of hepatic cytochromes P450 by dietary 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in the B6C3F1 mouse: Dosedependence and pharmacodynamics. Int J Toxicol 18, 123-130.
21. Omiecinski, C. J., Coslo, D. M., Chen, T., Laurenzana, E. M., and Peffer, R. C. (2011). Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol. Sci. 123, 550-562.
22. Petrick, J. S., and Klaassen, C. D. (2007). Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab. Dispos. 35, 1806-1815.
23. Ross, J., Plummer, S. M., Rode, A., Scheer, N., Bower, C. C., Vogel, O., Henderson, C. J., Wolf, C. R., and Elcombe, C. R. (2010). Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol. Sci. 116, 452-466.
24. Scheer, N., Ross, J., Rode, A., Zevnik, B., Niehaves, S., Faust, N., and Wolf, C. R. (2008). A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest. 118, 3228-3239.
25. Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q. H., Owens, I. S., Negishi, M., and Sueyoshi, T. (2001). The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232-1238.
26. Swales, K., and Negishi, M. (2004). CAR, driving into the future. Mol. Endocrinol. 18, 1589-1598.
27. Vyhlidal, C. A., Gaedigk, R., and Leeder, J. S. (2006). Nuclear receptor expression in fetal and pediatric liver: Correlation with CYP3A expression. Drug Metab. Dispos. 34, 131-137.
28. Zhang, J., Huang, W., Chua, S. S., Wei, P., and Moore, D. D. (2002). Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298, 422-424.